O-PHARM LIMITED - Accounts

Registered Number: 12799421 O-PHARM LIMITED
Statement of Financial Position
As at 31 August 2024

	2024		2023
	£	£	£	£
Fixed assets		30,000		0
Current assets	398,192		193,981
Creditors: amount falling due within one year	(126,422)		(67,258)
Net current assets		271,770		126,723
Total assets less current liabilities		301,770		126,723
Net assets		301,770		126,723


Capital and reserves		301,770		126,723

NOTES TO THE ACCOUNTS

General Information

O-PHARM LIMITED is a private company, limited by shares, registered in England and Wales, registration number 12799421, registration address 102 Clare Road, Maidenhead, SL6 4DQ.

The presentation currency is £ sterling.

Accounting policies

Significant accounting policies

Statement of compliance

These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

Basis of preparation

The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.

The financial statements are prepared in sterling which is the functional currency of the company.

Turnover

Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.

2.	Average number of employees Average number of employees during the year was 2 (2023 : 1).

For the year ended 31 August 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's Responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts.

The financial statements were approved by the director on 19 May 2025 and were signed by:

--------------------------------
Mohammad Omar Rafiq
Director

Registered Number: 12799421
England and Wales
Abridged Accounts

for the year ended 31 August 2024
for
O-PHARM LIMITED